| Literature DB >> 26518975 |
Chao Tian1, Zhili Zhang1, Shouxin Zhou1, Mengmeng Yuan1, Xiaowei Wang1, Junyi Liu1,2.
Abstract
Based on our previous work, seven N(5) -substituted 8,10-dideazatetrahydrofolate analogues and one 8-deazatetrahydrofolate analogue were designed and synthesized as human dihydrofolate reductase (hDHFR) inhibitors. All compounds were assayed versus DHFR and five different cancer cell lines. The biological assay indicated that replacing N(10) with carbon would significantly increase inhibitory activities against DHFR and cytotoxicities against cancer cell lines. Compound 19a with 4-amino and N(5) -formyl showed great antitumour activities against HL-60, Bel-7402 and BGC823 which were much better than MTX.Entities:
Keywords: 8,10-Dideazatetrahydrofolate; anticancer agents
Mesh:
Substances:
Year: 2015 PMID: 26518975 DOI: 10.1111/cbdd.12681
Source DB: PubMed Journal: Chem Biol Drug Des ISSN: 1747-0277 Impact factor: 2.817